| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $958.4M | +432.1% |
| R&D Expense | $388.5M | +64.1% |
| SG&A Expense | $813.8M | +87.1% |
| Operating Income | -$300.1M | +39.7% |
| Income Tax | $0 | — |
| Net Income | -$288.3M | +38.1% |
| EPS (Basic) | -$12.85 | +41.3% |
| EPS (Diluted) | -$12.85 | +41.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $198.7M | +98.7% |
| Accounts Receivable | $134.5M | +149.9% |
| Inventory | $74.8M | +119.7% |
| Current Assets | $1.25B | +20.6% |
| Total Assets | $1.26B | +20.9% |
| Current Liabilities | $310.3M | +83.3% |
| Long-term Debt | $339.9M | +189.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$189.6M | +58.4% |
| Capital Expenditures | $467K | -68.1% |
| Investing Cash Flow | $32.3M | +111.8% |
| Financing Cash Flow | $256.0M | -65.2% |
| Free Cash Flow | -$190.0M | +58.4% |
| Total Liabilities |
| $656.9M |
| +128.2% |
| Stockholders' Equity | $602.7M | -20.1% |